Capacitation and Ca2+ influx in spermatozoa: role of CNG channels and protein kinase G. (1st December 2013)

• Record Type: Journal Article
• Authors: Cisneros‐Mejorado, A.; Hernández‐Soberanis, L.; Islas‐Carbajal, M. C.; Sánchez, D.
• Is Part Of: Andrology. Volume 2:Number 1(2014:Jan.)
• Page Start: 145
• Page End: 154
• Publication Date: 2013-12-01
• Subjects: Andrology -- Periodicals; 616.65
• DOI: 10.1111/j.2047-2927.2013.00169.x
• Languages: English
• ISSNs: 2047-2919

Abstract

<abstract abstract-type="main" id="andr169-abs-0001"> <title>Summary</title> <p>Cyclic guanosine monophosphate (cGMP) has been recently shown to modulate in vitro capacitation of mammalian spermatozoa, but the mechanisms through which it influences sperm functions have not been clarified. There are at least two targets of cGMP, cyclic nucleotide‐gated (CNG) channels and cGMP‐dependent protein kinase (PKG), involved in several physiological events in mammalian spermatozoa. It has been suggested that CNG channels allow the influx of Ca²⁺ to cytoplasm during capacitation, whereas PKG could trigger a phosphorylation pathway which might also, indirectly, mediate calcium entry. Using the patch‐clamp technique in whole‐cell configuration, we showed how <italic>l‐cis‐</italic>Diltiazem (a CNG‐channel inhibitor) and KT5823 (a PKG inhibitor) decreased significantly the amplitude of macroscopic ion currents in a dose–response manner, and decreased in vitro capacitation. The inhibition of CNG channels completely abolishes the Ca²⁺ influx induced by cyclic nucleotides in mouse spermatozoa. This work suggests that the downstream cGMP pathway is required in mammalian sperm capacitation and the mechanisms involved include CNG channels and PKG, highlighting these molecules as important therapeutic targets for infertility treatments or to develop new male contraceptives.</p> </abstract>